comparemela.com

Latest Breaking News On - Testing services agreement - Page 1 : comparemela.com

Entheon Biomedical Corp Launches HaluGen s Psychedelics Genetic Test

Entheon Biomedical Corp. Launches HaluGen s Psychedelics Genetic Test HaluGen s DNA genetic testing provides insights into the sensitivity and risks associated with psychedelic-assisted psychotherapy Vancouver, British Columbia (Newsfile Corp. - April 6, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ( Entheon or the Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, announces the launch of the industry s first Psychedelics Genetic Test Kit, developed by wholly-owned subsidiary, HaluGen Life Sciences Inc. ( HaluGen ), and that it is now available for sale within Canada. HaluGen s psychedelic pre-screening platform and DNA testing provides genetic, personal and familial insights to better inform one s psychedelic assisted therapy experience. By obtaining DNA test results, individuals and healthcare professionals are equipped with data to improve psychedelic assisted therapy patient care and reduce side effects and risk. Th

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.